Whole Body Vibration and Tonic Vibration Reflex

High-Frequency Whole Body Vibration Activates Tonic Vibration Reflex

Whole-body vibration (WBV) has beneficial neuromuscular effects on muscle strength increase. Supraspinal, spinal, and peripheral mechanisms have been proposed to explain these beneficial effects. The most commonly proposed explanatory mechanism is spinal segmental reflexes. However, the neuronal circuit and receptors of the reflex response have not been defined precisely. A group of researchers found that the reflex system is the Tonic vibration reflex (TVR) under the neuromuscular effects of WBV; Other researchers claim that WBV activates a different spinal reflex than TVR. Tonic vibration reflex is a polysynaptic reflex that occurs as a result of muscle spindle activation, in which more than 100 Hz vibrations are applied to the belly or tendon of the muscle. A group of researchers argues that WBV activates the spinal reflex response, but this reflex response is different from TVR. According to them, WBV-induced reflex (WBV-IR) response latency is longer than TVR latency. WBV activates TVR at very attenuated amplitude; WBV activates a different spinal reflex with longer latency at medium and high amplitude vibration. They reported that although the H-reflex, T-reflex, and TVR latency was longer in the spastic soleus muscle than normotonic soleus muscle, where the muscle spindle and Ia afferent pathway were hyperactive. However, the WBV-IR latency was similar in both spastic and normotonic soleus muscle. According to our hypothesis, the reflex system activated by WBV changes depending on vibration frequency: if the high-frequency (100-150 Hz) WBV is applied, the tonic vibration reflex is activated; if the low-frequency (30-40 Hz) WBV is applied, the bone myoregulation reflex is activated. The purpose of this research is to test this hypothesis.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Seven healthy recreationally active males between the ages of 26 and 35 volunteered to participate in this study. All subjects received pre-study informed consent. All experimental procedures were designed with the Helsinki declaration in mind and approved by the local ethics committee. All subjects performed a familiarization trial to acclimate subjects to the WBV stimulus. WBV-IR and TVR latency of soleus muscle were then measured in the quiet standing position. The vibrations (WBV or tendon) sequence were applied randomly to negate any order/time effect. The subject rested for five minutes between the WBV and tendon vibration. The WBV application was delivered using a PowerPlate Pro5 device (PowerPlate International, Amsterdam, The Netherlands). First, 30 Hz, low amplitude (1 mm) vibration with a duration of 30 seconds was applied to each subject for familiarization purposes. After three minutes of rest, low-amplitude (1 mm) WBV testing was performed in random order in quiet standing positions. In a WBV set, three different vibration frequencies (30, 35, and 40 Hz), each lasting for 30 s with 3-s rest intervals, were delivered. The local vibration was applied to the mid-point of the right Achilles tendon by using a custom-made vibrator. The head of the tendon vibrator was in light contact with the underlying skin. Tendon vibrations were applied by the same researcher. Three different vibration frequencies (100, 135, and 150 Hz) were delivered, lasting for 30 s with 3-s rest intervals. A local vibration was applied to the right heel using the same custom-made vibrator. Tendon vibrations were applied by the same researcher. Three different vibration frequencies (100, 135, and 150 Hz) were delivered, lasting for 30 s with 3-s rest intervals.

The surface electromyography (SEMG) recorded from the soleus and acceleration data were collected simultaneously using data acquisition and analysis system (PowerLab ® software, ADInstruments, Oxford, UK). Disposable self-adhesive bipolar Ag/AgCl (Covidien Kendall, Dublin, Ireland) surface electrodes were placed on the right soleus belly 4 cm apart. The skin overlying the muscle was shaved, light abrasion was applied, and the skin was cleaned with alcohol to reduce the skin resistance. To determine TVR latency, a light (2.9 g) piezoelectric accelerometer (LIS344ALH, ECOPACK®, Mansfield, TX, USA) was firmly fixed using adhesive tape on the skin overlying the right Achilles tendon. To determine WBV-IR latency, an identical accelerometer was firmly mounted on the WBV platform. The acceleration and SEMG signals were recorded at a sampling frequency of 20 kHz. Accelerometer recordings were filtered with a high-pass filter set at 5 Hz. SEMG data obtained during WBV were bandpass filtered at 80-500 Hz to reduce vibration-induced movement artifacts and then full-wave rectified. Similarly, SEMG data obtained during tendon vibration were bandpass filtered at 160-500 Hz and then full-wave rectified. WBV-IR and TVR latencies were then calculated by using the cumulative average method.

An electronic reflex hammer (Elcon, Germany) was used to determine T-reflex latency. All latencies were normalized to the body height of each participant.

Latency was expressed as milliseconds (ms).

Study Type

Interventional

Enrollment (Actual)

7

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey, 34173
        • Istanbul Physical Medicine Rehabilitation Training & Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Being healthy
  • Being a young adult (20-45 years old)
  • Volunteer

Exclusion Criteria:

  • Scar, dermatitis, etc. in the skin tissue
  • Kidney stone history
  • Fracture in the lower extremity, history of orthopedic surgery
  • Heart disease, Hypertension
  • Dizziness
  • Metabolic bone diseases, including osteoporosis
  • History of bone occupying lesion, neoplasia, osteomyelitis
  • Degenerative, inflammatory diseases of the joints of the lower extremities
  • Lower extremity thrombophlebitis
  • Lower extremity motor loss, sensory loss, muscle atrophy
  • Subjects who cannot tolerate whole-body vibration

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Vibration
Vibration (WBV, heel, and tendon vibration) was applied to participants
whole-body vibration, heel and soleus tendon vibrations were applied to the human body

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
WBV-IR latency
Time Frame: during intervention, an average of 1 minute
Whole-body vibration induced reflex latency
during intervention, an average of 1 minute
TVR latency
Time Frame: during intervention, an average of 1 minute
Tonic vibration reflex latency
during intervention, an average of 1 minute
Heel vibration induced reflex latency
Time Frame: during intervention, an average of 1 minute
Vibration was applied to the right heel. The reflex latency induced by the heel vibration was measured.
during intervention, an average of 1 minute
T-reflex latency
Time Frame: during intervention, an average of 1 minute
Latency of the Achilles tendon reflex
during intervention, an average of 1 minute

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: İLHAN KARACAN, Istanbul Physical Medicine Rehabilitation Training & Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 27, 2021

Primary Completion (Actual)

December 30, 2021

Study Completion (Actual)

December 31, 2021

Study Registration Dates

First Submitted

January 3, 2022

First Submitted That Met QC Criteria

January 22, 2022

First Posted (Actual)

January 27, 2022

Study Record Updates

Last Update Posted (Actual)

January 27, 2022

Last Update Submitted That Met QC Criteria

January 22, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • WBVTVR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vibration; Exposure

Clinical Trials on vibration

Subscribe